Annual D&A
$259.00 K
+$11.00 K+4.44%
31 December 2023
Summary:
Cara Therapeutics annual depreciation & amortization is currently $259.00 thousand, with the most recent change of +$11.00 thousand (+4.44%) on 31 December 2023. During the last 3 years, it has risen by +$50.00 thousand (+23.92%). CARA annual D&A is now -82.32% below its all-time high of $1.47 million, reached on 31 December 2016.CARA Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$73.00 K
-$4000.00-5.19%
30 September 2024
Summary:
Cara Therapeutics quarterly depreciation & amortization is currently $73.00 thousand, with the most recent change of -$4000.00 (-5.19%) on 30 September 2024. Over the past year, it has increased by +$14.00 thousand (+23.73%). CARA quarterly D&A is now -90.00% below its all-time high of $730.00 thousand, reached on 31 March 2016.CARA Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$274.00 K
+$14.00 K+5.38%
30 September 2024
Summary:
Cara Therapeutics TTM depreciation & amortization is currently $274.00 thousand, with the most recent change of +$14.00 thousand (+5.38%) on 30 September 2024. Over the past year, it has increased by +$36.00 thousand (+15.13%). CARA TTM D&A is now -83.90% below its all-time high of $1.70 million, reached on 30 June 2016.CARA TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CARA Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4.4% | +23.7% | +15.1% |
| 3 y3 years | +23.9% | +17.7% | +10.5% |
| 5 y5 years | -30.0% | +46.0% | +35.6% |
CARA Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +23.9% | -11.0% | +73.8% | at high | +15.1% |
| 5 y | 5 years | -30.0% | +30.8% | -11.0% | +73.8% | at high | +41.2% |
| alltime | all time | -82.3% | +30.8% | -90.0% | +73.8% | -83.9% | +41.2% |
Cara Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $73.00 K(-5.2%) | $274.00 K(+5.4%) |
| June 2024 | - | $77.00 K(+83.3%) | $260.00 K(+7.0%) |
| Mar 2024 | - | $42.00 K(-48.8%) | $243.00 K(-6.2%) |
| Dec 2023 | $259.00 K(+4.4%) | $82.00 K(+39.0%) | $259.00 K(+8.8%) |
| Sept 2023 | - | $59.00 K(-1.7%) | $238.00 K(-0.8%) |
| June 2023 | - | $60.00 K(+3.4%) | $240.00 K(-1.2%) |
| Mar 2023 | - | $58.00 K(-4.9%) | $243.00 K(-2.0%) |
| Dec 2022 | $248.00 K(0.0%) | $61.00 K(0.0%) | $248.00 K(-0.4%) |
| Sept 2022 | - | $61.00 K(-3.2%) | $249.00 K(-0.4%) |
| June 2022 | - | $63.00 K(0.0%) | $250.00 K(+0.8%) |
| Mar 2022 | - | $63.00 K(+1.6%) | $248.00 K(0.0%) |
| Dec 2021 | $248.00 K(+18.7%) | $62.00 K(0.0%) | $248.00 K(0.0%) |
| Sept 2021 | - | $62.00 K(+1.6%) | $248.00 K(+4.6%) |
| June 2021 | - | $61.00 K(-3.2%) | $237.00 K(+5.8%) |
| Mar 2021 | - | $63.00 K(+1.6%) | $224.00 K(+7.2%) |
| Dec 2020 | $209.00 K(+5.6%) | $62.00 K(+21.6%) | $209.00 K(+7.2%) |
| Sept 2020 | - | $51.00 K(+6.3%) | $195.00 K(+0.5%) |
| June 2020 | - | $48.00 K(0.0%) | $194.00 K(-1.0%) |
| Mar 2020 | - | $48.00 K(0.0%) | $196.00 K(-1.0%) |
| Dec 2019 | $198.00 K(-46.5%) | $48.00 K(-4.0%) | $198.00 K(-2.0%) |
| Sept 2019 | - | $50.00 K(0.0%) | $202.00 K(-12.6%) |
| June 2019 | - | $50.00 K(0.0%) | $231.00 K(-21.7%) |
| Mar 2019 | - | $50.00 K(-3.8%) | $295.00 K(-20.3%) |
| Dec 2018 | $370.00 K | $52.00 K(-34.2%) | $370.00 K(-16.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | $79.00 K(-30.7%) | $443.00 K(-9.4%) |
| June 2018 | - | $114.00 K(-8.8%) | $489.00 K(-1.8%) |
| Mar 2018 | - | $125.00 K(0.0%) | $498.00 K(+0.6%) |
| Dec 2017 | $495.00 K(-66.2%) | $125.00 K(0.0%) | $495.00 K(+1.2%) |
| Sept 2017 | - | $125.00 K(+1.6%) | $489.00 K(+6.1%) |
| June 2017 | - | $123.00 K(+0.8%) | $461.00 K(-46.2%) |
| Mar 2017 | - | $122.00 K(+2.5%) | $857.00 K(-41.5%) |
| Dec 2016 | $1.47 M(+74.6%) | $119.00 K(+22.7%) | $1.47 M(-8.7%) |
| Sept 2016 | - | $97.00 K(-81.3%) | $1.60 M(-5.7%) |
| June 2016 | - | $519.00 K(-28.9%) | $1.70 M(+23.7%) |
| Mar 2016 | - | $730.00 K(+181.9%) | $1.38 M(+64.0%) |
| Dec 2015 | $839.00 K(+7.2%) | $259.00 K(+33.5%) | $839.00 K(+8.5%) |
| Sept 2015 | - | $194.00 K(+0.5%) | $773.00 K(-0.4%) |
| June 2015 | - | $193.00 K(0.0%) | $776.00 K(-0.4%) |
| Mar 2015 | - | $193.00 K(0.0%) | $779.00 K(-0.5%) |
| Dec 2014 | $783.00 K(-0.8%) | $193.00 K(-2.0%) | $783.00 K(-0.5%) |
| Sept 2014 | - | $197.00 K(+0.5%) | $787.00 K(0.0%) |
| June 2014 | - | $196.00 K(-0.5%) | $787.00 K(-0.1%) |
| Mar 2014 | - | $197.00 K(0.0%) | $788.00 K(-0.1%) |
| Dec 2013 | $789.00 K(-22.7%) | $197.00 K(0.0%) | $789.00 K(+33.3%) |
| Sept 2013 | - | $197.00 K(0.0%) | $592.00 K(+49.9%) |
| June 2013 | - | $197.00 K(-0.5%) | $395.00 K(+99.5%) |
| Mar 2013 | - | $198.00 K | $198.00 K |
| Dec 2012 | $1.02 M(-12.7%) | - | - |
| Dec 2011 | $1.17 M | - | - |
FAQ
- What is Cara Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Cara Therapeutics?
- What is Cara Therapeutics annual D&A year-on-year change?
- What is Cara Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Cara Therapeutics?
- What is Cara Therapeutics quarterly D&A year-on-year change?
- What is Cara Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Cara Therapeutics?
- What is Cara Therapeutics TTM D&A year-on-year change?
What is Cara Therapeutics annual depreciation & amortization?
The current annual D&A of CARA is $259.00 K
What is the all time high annual D&A for Cara Therapeutics?
Cara Therapeutics all-time high annual depreciation & amortization is $1.47 M
What is Cara Therapeutics annual D&A year-on-year change?
Over the past year, CARA annual depreciation & amortization has changed by +$11.00 K (+4.44%)
What is Cara Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of CARA is $73.00 K
What is the all time high quarterly D&A for Cara Therapeutics?
Cara Therapeutics all-time high quarterly depreciation & amortization is $730.00 K
What is Cara Therapeutics quarterly D&A year-on-year change?
Over the past year, CARA quarterly depreciation & amortization has changed by +$14.00 K (+23.73%)
What is Cara Therapeutics TTM depreciation & amortization?
The current TTM D&A of CARA is $274.00 K
What is the all time high TTM D&A for Cara Therapeutics?
Cara Therapeutics all-time high TTM depreciation & amortization is $1.70 M
What is Cara Therapeutics TTM D&A year-on-year change?
Over the past year, CARA TTM depreciation & amortization has changed by +$36.00 K (+15.13%)